Chemical Chaperones for the Prevention of Antipsychotic-Induced Impairments in Glucose Metabolism
Year: 2026
Type: dissertation
Abstract: Antipsychotics can lead to significant weight gain and glucose dysregulation. Acutely, they induce glucose dysregulation independent of weight gain. This effect involves the hypothalamus, where insulin and nutrients suppress endogenous glucose production (EGP) to maintain glucose homeostasis. The antipsychotic olanzapine (OLA) blocks the ability of intracerebroventricular (ICV) insulin to suppress EGP, likely through hypothalamic endoplasmic reticulum (ER) stress, which disrupts glucose metabolism. Chemical chaperones such as sodium 4-phenylbutyric acid (PBA) alleviate ER stress and improve glycemic control. Therefore, this study examined whether PBA could reverse OLA-induced insulin resistance. In preparation for pancreatic euglycemic clamps, Sprague Dawley rats underwent ICV cannulation for insulin delivery and intravenous catheterization for infusions and sampling. ICV insulin suppressed EGP, an effect abolished by OLA, however, restored with PBA co-administration. These findings suggest that PBA resolves olanzapine-induced impairment of central insulin action, highlighting its potential as a therapeutic to mitigate antipsychotic-related glucose dysregulation.
Source: TSpace (University of Toronto)
Author: Humber, Bailey Edward Troy
Institution: University of Toronto
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Novo Nordisk
OpenAlex ID: W7203961781
